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Liposarcoma is one of the most frequently occurring soft tissue sarcomas in adulthood. The majority of liposarcomas arise in the
lower extremities and retroperitoneum, while the incidence of this tumor in the head and neck region is reported to be extremely
low, comprising 1.8%–6.2% of all cases. Nasopharyngeal liposarcoma is exceptionally rare, with only three cases having been
reported in the English literature. This paper presents a case of a nasopharyngeal liposarcoma, treated with endoscopic tumor
debulking, followed by adjuvant chemotherapy and radiotherapy, and reviews the current literature with regard to diagnosis and
management of such lesions. Most authors agree that the imaging modality of choice is magnetic resonance imaging. Although
radiographic ﬁndings usually support diagnosis, the imaging characteristics of such lesions may considerably vary, depending on
the histological subtype and the macroscopic appearance of the tumor. The treatment of choice is complete surgical excision when
possible. Although the role of postoperative radiotherapy is not clearly deﬁned, some authors support that radiotherapy might
delay or prevent local recurrence. However, there is no adequate evidence that the combination of surgery and radiotherapy lowers
the possibility of distant metastasis of the head and neck liposarcomas. The role of adjuvant or neoadjuvant chemotherapy still
remains controversial.
1.Introduction
Liposarcoma is a quite common soft tissue malignant tumor
in adults. In fact, it is second only to ﬁbrosarcoma, as the
most frequently occurring soft tissue sarcoma in adulthood
[1–3]. The majority of liposarcomas arise in the lower ex-
tremities and retroperitoneum, while the incidence of this
t u m o ri nt h eh e a da n dn e c kr e g i o ni sr e p o r t e dt ob ee x t r e m -
ely low, comprising 1.8%–6.2% of all cases [1, 4, 5]. Naso-
pharyngeal liposarcoma is exceptionally rare, with only three
cases having been presented in the English literature [1, 5,
6]. The aim of the present paper is to report a case of a
nasopharyngeal liposarcoma, treated with endoscopic tum-
ordebulking,followedbyadjuvantchemotherapyandradio-
therapy. We also review the current literature, with regard to
diagnosis and treatment of such rare malignancies.
2.CaseReport
A 58-year-old male presented to our department with a 6-
month history of nasal obstruction and right otalgia. Subse-
quent nasopharyngeal endoscopy revealed a right-sided
mass, situated at the posterior wall of the nasopharynx (Fig-
ure 1(a)). High-resolution computed tomography (CT), as
well as magnetic resonance imaging (MRI), showed a right-
sided mass, measuring approximately 2 × 3 × 1.8cm(Fig-
ure 2). There was no imaging evidence of cervical lymphad-
enopathy.
As the tumor was not possible to be radically excised, our
patient underwent an endoscopic biopsy of the mass along
with tumor debulking, under general anesthesia.
The histopathological examination showed a myxoid-
round cell liposarcoma, with moderate diﬀerentiation and2 Case Reports in Medicine
(a) (b)
Figure 1: (a) Preoperative endoscopic image of the right-sided tumor situated at the posterior wall of the nasopharynx. (b) Endoscopic
follow-up image of the nasopharynx 14 months after postoperative radiotherapy.
(a) (b)
Figure 2: CT (a) and MRI (b) imaging of the tumor (red arrows).
hemorrhageinﬁltration.Immunoperoxidasestainswerepos-
itive for S100 protein, vimentin, CD68 in histiocytes, and
Ki67 in lessthan10% of tumorcells,being negative forSMA,
NSE (Figure 3).
Right after the operation, our patient underwent 6 cycles
of adjuvant chemotherapy (a doxorubicin-based regimen
was administered), followed by radiotherapy (66Gy in 33
fractions). The patient showed no residual tumor on endo-
scopyandMRIimagingbytheendofradiotherapy.Thereare
still no signs of recurrence on follow-up endoscopy (Figure
1(b)) and MRI imaging, 14 months after radiotherapy.
3. Discussion
Liposarcoma is the second most common soft tissue sar-
coma, accounting for 14–20% of all soft tissue malignancies
[1, 2, 4]. This tumor shows a male preponderance, with the
vast majority of the cases diagnosed in adults, between 40
and 60 years of age [2, 7]. Liposarcoma usually arises in
the lower extremities and retroperitoneum [1–4]. However,
1.8%–6.2% of these tumors are found in the head and
neck region [1, 2, 4, 7]. Nasopharyngeal liposarcoma is
exceedingly rare. Only three cases have been described in the
English literature [1, 5, 6]( Table 1).
The review of the English literature showed that only
a few publications have directly addressed head and neck
liposarcomas,usuallypresentingquitelimitedpatients’series
[8]. Based on data and knowledge from the largest reported
series of head and neck liposarcomas [8–10], a comprehen-
sive discussion focusing on demographic and clinical/histo-
pathological features, sites of presentation, treatment strate-
gies, and ﬁnal outcome, in terms of survival, metastasis, and
local recurrence rates, was attempted.
The mean age of presentation is between 40 and 46 years,
with a peak at the 6th and 7th decades [8–10]. Liposarcomas
of the head and neck show a male preponderance (male-
to-female ratio is reported to vary between 1.5 and 1.85/1
[8–10]). The neck or parotid region is reported as the most
common primary tumor site, followed by skull base/orbit,
upper aerodigestive tract (larynx, pharynx, and oral cavity),
and scalp or face [8, 9].
Liposarcoma originates from primitive mesenchymal
cells. It is divided into ﬁve major histologic subtypes: wellCase Reports in Medicine 3
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(c) (d)
Figure 3: Histopathological images of the presented case. (a) Submucosal (surface epithelium in upper right) liposarcoma (H&E stain, ×25)
(b) Myxoid liposarcoma, with lipoblastic diﬀerentation (H&E ×100) (c) Liposarcoma with round cells (H&E ×100) (d) Mostly nuclear and
some cytoplasmic immunoreactivity for S100 protein in the tumor cells (×100).
Table 1: Cases of nasopharyngeal liposarcoma, reported in the English literature.
Case no. Study Patient sex and
age (years) Histological type Treatment Follow-up Patient’s status by the
end of follow-up
1 Knowles and
Huggill Male 12 Not clearly classiﬁed Radiotherapy 10 months Dead
2 Nageris et al. Female 28
Myxoid stroma, tumour
cells with pleomorphic
nuclei
Incomplete excision plus
postoperative radiotherapy 11 years Alive, Disease-free
3 Chakraborty et al. Female 37 Well-diﬀerentiated,
sclerosing subtype
Debulking-biopsy followed
by radical radiotherapy and
stereotactic radiotherapy
Not clearly
deﬁned
Residual tumor
existed after
treatment
4 Present case 2011 Male 58 Myxoid type
Endoscopic debulking,
adjuvant chemotherapy,
and radiotherapy
14 months Alive, disease-free
diﬀerentiated, myxoid, dediﬀerentiated, round-cell, and ple-
omorphic subtype [1, 2, 4, 11]. The most common histolog-
ical type is the well-diﬀerentiated one (this type includes the
adipocytic, sclerosing and inﬂammatory subtype), account-
ing for 40–50% of all types, while the most infrequent
type is pleomorphic liposarcoma. Myxoid type liposarcoma
(similar to the tumor in our case) is composed of three
main tissue components, proliferating lipoblasts at varying
stages of diﬀerentiation (Figure 3(b)), a delicate plexiform
capillary pattern, and a myxoid matrix containing abundant
nonsulfated glycosaminoglycans [1, 2, 4, 12].
Well-diﬀerentiated, myxoid, and pleomorphic types are
the most commonly found, while round-cell type lesions are
quite rarely conﬁrmed [8–10]. The well-diﬀerentiated tum-
ors appear to have excellent prognosis: Golledge et al. re-
ported that none of the patients, diagnosed with such histo-
logical subtypes, died during the follow-up period (mean
follow-up was 5 years [8]). On the contrary, round-cell and
pleomorphic subtypes are usually related with poor progno-
sis [8–10].
Early diagnosis of liposarcomas is quite rare mainly due
to the fact that these tumors are usually painless, gradually4 Case Reports in Medicine
developing lesions. Various compressive symptoms may be
encountered, depending on the location and the size of the
tumor. In the reported cases of nasopharyngeal lesions, as
wellasinourcase,themainsymptomswereprogressivenasal
obstruction along with unilateral persisting otitis media with
eﬀusion and referred otalgia [1, 5, 6].
Most authors agree that the imaging modality of choice
is MRI [1, 13, 14]. However, computed tomography (CT) is
still recommended, especially when data regarding bony or
cartilage erosion is required. Although radiographic ﬁndings
usuallysupportdiagnosis,theimagingcharacteristicsofsuch
lesions may considerably vary, depending on the histological
subtype and the macroscopic appearance of the tumor [1,
13, 14]. In our case, the myxoid type liposarcoma of the
nasopharynx was quite well deﬁned on MRI with homoge-
nous T1 and T2 relaxation times almost similar to those
of water. On the other hand, the well-diﬀerentiated lesions,
which are predominantly fatty, usually show a high signal
intensity on T1-weighted sequences and intermediate signal
on T2-weighted sequences, with signal attenuation follow-
ing fat saturation [13, 14].
Provided that nasopharyngeal liposarcomas are exceed-
ingly rare, there are very limited reports in the literature
with regard to the management of such malignancies [1, 5,
6]. Most therapeutic protocols and experience are basically
based on treatment strategies involved in liposarcomas of the
head and neck or other anatomic regions [2–4, 8–10, 15, 16].
Liposarcoma is, like other soft tissue sarcomas, primarily
a surgical disease. The main goal of surgery is to remove the
tumour entirely and prevent recurrence [8–10]. Incomplete
resection seems to aﬀect prognosis by increasing the rate of
local recurrence or distant metastases in aggressive lesions,
such as round-cell or pleomorphic liposarcomas [2, 4, 12].
However, treatment strategies in head and neck liposar-
comas are usually signiﬁcantly diﬀerent, compared to those
related to similar lesions of other regions [8–10]. This fact
reﬂects the limitations caused by anatomical boundaries, as
well as expected comorbidity [8, 10]. The site of the tumor,
when situated in the head and neck area, might produce
serious diﬃculties with regard to surgical treatment. Radical
excision, with suﬃcient healthy margins, is usually quite
diﬃcult tobe achieved, mainlyduetothespeciﬁcanatomical
relationships of the lesions. Besides, the expected postop-
erative morbidity is considered to be quite unacceptable in
manycases.Forexample,swallowingorrespirationproblems
might delay patients’ recovery or even expose their lives
to serious risks. Such functional deﬁcits encountered may
vary signiﬁcantly, depending on the size and location of the
individual tumor, and are associated with the removal of
tissues adjacent to the tumour (i.e., vessels, muscles, nerves,
etc. [10]). Although reconstruction of postresection deﬁcits
can, in some instances, be advocated to minimize these
eﬀects, this is not always easy to be performed. Therefore,
the quality of life of such patients remains seriously aﬀected
postoperatively.
In fact, all cases of nasopharyngeal liposarcomas, includ-
ing the present case, were related with various diﬃculties,
aﬀecting treatment strategy. Management strategy and para-
meters, as well as ﬁnal outcome of those four cases, are pre-
sented and commented below in detail. We also attempt to
indicate how the outcomes of potentially altered treatment
in such cases compare to the standard treatment of liposar-
comas outside the head and neck region.
In Knowles and Huggill’s case [6] (a 12-year-old boy), a
small lesion, about 2cm in diameter, was palpated just be-
hind the right side of the mandible, along with a few small
cervical lymph nodes bilaterally. The nose and throat region
was clinically healthy and so was the nasopharynx. A month
later, a signiﬁcantly larger mass, extending from the vault
of the nasopharynx down to the oropharynx, was palpated.
The mass and the adenoids were only biopsied under general
anesthesia, because the tumor was considered to be already
unresectable,bytheauthors.Therefore,thepatientwastreat-
ed with radiotherapy alone. Unfortunately, 10 months later,
extended lung metastases were identiﬁed. The patient’s con-
dition steadily deteriorated, and he ﬁnally died, 2 months
later.
In Nageris et al.’s case [5] (a 28-year-old woman), the
tumor was situated at the lower nasopharyngeal wall. The
patient underwent surgery via intraoral approach but the
tumor was not possible to be radically excised. Therefore,
after histopathological conﬁrmation, the patient was treated
with adjuvant postoperative radiotherapy. The authors re-
port that the patients is alive and disease free, eleven years
postoperatively.
In Chakraborty et al.’s case [1] (a 37-year-old woman),
the tumor was situated at the posterior aspect of the inferior
turbinate, adjacent to the eustachian tube oriﬁce. After the
initial endoscopic debulking and biopsy was performed, the
authors suggested surgical resection plus radiotherapy, as a
deﬁnite therapy. However, the patient declined surgery. As a
result, the case was actually treated with radical radiotherapy
alone. Right after radiotherapy, follow-up endoscopy and
imaging studies revealed residual tumor. This was also
conﬁrmed histopathologically. Surgical resection was again
suggested but the patient declined. No details, regarding
further treatment or follow-up, are reported by the authors.
In our case (a 58-year-old male), the right-sided tumor
was situated at the posterior wall of the nasopharynx. As the
lesionwasnotpossibletoberadicallyexcised,thepatientwas
treated with endoscopic debulking and adjuvant chemother-
apy (a doxorubicin-based regimen) and radiotherapy. The
patient is alive, showing no signs of residual tumor, on both
follow-up endoscopy and imaging studies, 14 months after
radiotherapy.
Obviously, radical tumor excision was not possible in all
reportedcasesofnasopharyngealliposarcoma,mainlydueto
anatomical limitations correlated with the site of the lesion
[1, 5, 6]. Radiotherapy alone, or as adjuvant treatment, was
involved in all cases [1, 5, 6]. In two out of the four cases [5],
ﬁnal outcome was reported to be excellent: the patients were
alive and disease-free 11 years and 14 months after initial
treatment, respectively.
On the other hand, in most cases of liposarcomas out-
side the head and neck region, surgery alone or a com-
bined modality approach of preoperative or postoperative
radiation therapy is used by most authors [17, 18]. The role
of chemotherapy is less well deﬁned [17, 18]. The progno-Case Reports in Medicine 5
sis depends on several factors, including the patient’s age, the
size, the histologic grade, the stage of the tumour, and the
extent of resection. Factors associated with a poorer prog-
nosis include age older than 60 years, tumours larger than
5cm, and high-grade histology. While low-grade tumours
are usually curable by surgery alone, higher-grade tumours
are associated with higher local-treatment failure rates and
increasedmetastaticpotential[18].Whenfeasible,widemar-
gin function-sparing surgical excision is the cornerstone of
eﬀective treatment, with the goal of preservation of a func-
tional extremity [17]. This may be facilitated by soft tissue
reconstructive surgery. Eﬀective treatment of retroperitoneal
sarcomas requires removal of all gross disease, while sparing
adjacent viscera not invaded by tumor. The prognosis for
patients with high-grade retroperitoneal lesions is less fa-
vourable than for patients with tumors of other sites, main-
ly because of the diﬃculty in completely resecting these tum-
ours and the limitations placed on high-dose radiation ther-
apy [17, 18].
Arecentoriginalstudy,conductedintheUSA,cametoan
interesting conclusion, regarding the prognosis and the ﬁnal
outcome of liposarcomas in the head and neck region, com-
paredtootheranatomicallocations:withamedianfollow-up
of 45 months, Smith et al. (2011) [19] concluded that 5-year
overall survival rate was similar among extremity (86.6%),
trunk (84.6%), and head and neck (88.4%) locations. On the
contrary, overall survival rate was statistically worse (77.4%)
for retroperitoneal/intra-abdominal cases. Moreover, 5-year
disease-speciﬁc survival was reported to be similar among
extremity (98%), thorax (90%), and head and neck (93.2%)
locations but statistically worse for both trunk (92.3%) and
retroperitoneal/intra-abdominal cases.
Although surgery with negative margins is very well doc-
umented as the treatment of choice for all histopathological
subtypes of head and neck liposarcomas, routine regional
lymph node dissection is not generally recommended, as
node metastases of head and neck liposarcomas are quite
rare [8, 10]. Patients with low-grade tumors, such as well-
diﬀerentiated or myxoid subtypes, can be observed after
surgery, provided that the tumors had no local extension,
and they were radically excised, with negative margins. Post-
operative radiotherapy is advocated by most authors, espe-
cially in patients with large tumors, high-grade lesions, local
extension and incomplete resection-positive margins [8, 10,
20]. Postoperative adjuvant radiotherapy appears to decrease
the rate of local recurrence (from 60% to 40%) but it does
not seem to improve the overall survival rate or the rate of
metastasis [8–10].
Although the role of chemotherapy is not clearly deﬁned,
some authors support the use of neoadjuvant chemotherapy
regimens (doxorubicin and dacarbazine based), in selected
patients with high-grade tumours or lesions with complex
anatomical subsites, reporting quite satisfactory results, es-
pecially in terms of local control of the disease [2, 21].
In our case, although the liposarcoma proved to be of
low-grade, we decided to involve adjuvant chemotherapy
along with radiotherapy, because the tumor was quite large
andradicalexcisionwasnotpossibletobeperformed,mainly
due to the anatomical location of the mass.
As far as the ﬁnal outcome is concerned, the study of
the literature concludes that both disease-speciﬁc and overall
survival rates of low-grade head and neck liposarcomas
(well-diﬀerentiated or myxoid subtypes) are much higher,
compared to those in patients with pleomorphic or round-
cell subtypes [8–10]. Davis et al. reported a disease-speciﬁc
survival of 100% for well diﬀerentiated and myxoid liposar-
comas, versus 60% and 40% for round cell and pleomorphic
tumors, respectively [9]. Gritli et al. reported 5-year survival
ratesof75%forwell-diﬀerentiated,70%formyxoid,22%for
pleomorphic and 0% for round-cell liposarcomas [10]. It is
quite commonly accepted that patients treated with surgery
alone appear to have signiﬁcantly better outcome: the 5-year
survival rate is reported to be better, compared with that of
patients treated with combined therapeutic modalities (5-
year survival rates 83% versus 63% [8]). Moreover, Golledge
supported that local recurrence is also less common in pa-
tients treated with surgery alone [8]. This observation ob-
viously reﬂects the fact that more aggressive tumors are often
treated with combined strategies. However, in the recent
study of Davis et al. [9], there were no statistically signiﬁcant
diﬀerences between patients treated with surgery alone and
those treated with surgery and adjuvant therapies, in terms
of both local recurrence and distant metastasis.
Local recurrence is considered to be quite common (re-
ported recurrence rates are between 36% and 63%), espe-
cially in younger patients and in more aggressive high-grade
liposarcomas or tumors with local extension into surround-
ing tissues [8–10]. Such patients should be selected for more
aggressive surgical treatment or even combined surgery and
adjuvant radiotherapy. Distant metastases (bony, hepatic,
adrenal, and pulmonary) are quite rarely identiﬁed by the
time of initial diagnosis and are mostly found in women and
more aggressive high-grade/larger tumors (>5cm), usually
treated with combined therapeutic modalities (these diﬀer-
ences are not documented as statistically signiﬁcant [8, 9]).
The site of the lesion also appears to aﬀect prognosis:
scalp, facial, and laryngeal liposarcomas are reported to have
a relatively better prognosis, probably due to earlier diagno-
sis,comparedwithintraoral,pharyngeal,ornecktumors[8].
In our case, although the lesion was <5cm in diameter
and the histological subtype was of low grade, radical exci-
sion was not possible. We decided to use both adjuvant
chemotherapy and radiotherapy because of the location of
the tumor, which could make the identiﬁcation of local re-
currence very diﬃcult, especially without the use of biopsies.
The outcome is very satisfactory, as the patient is alive and
disease-free (no signs of local recurrence, regional node, or
distant metastasis), 14 months after radiotherapy.
4. Conclusions
Liposarcoma is a soft tissue malignant tumor rarely occur-
ring in the head and neck region. Nasopharyngeal liposarco-
mas are even more rarely diagnosed, with only three cases
having been reported in the English literature. Treatment
of choice is surgical excision with the wider possible mar-
gins, followed by postoperative radiotherapy and adjuvant
chemotherapy in selected cases.6 Case Reports in Medicine
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